So this article is written to do one thing well: help you tell the difference between the bleeding that is ordinary at midlife and the bleeding that buys you an appointment this week.
The one rule that matters most: bleeding after menopause is never normal
Once you have gone 12 consecutive months without a period, your uterus is meant to be quiet. Any bleeding after that point — a single pink smear on the toilet paper, brown spotting in your underwear, bleeding after sex, a bleed that lasts an hour and never comes back — is called postmenopausal bleeding, and it is an abnormal finding until proven otherwise.
How worried should you be? Honestly: pooled data across studies show that around 9% of women with postmenopausal bleeding turn out to have endometrial cancer. That means roughly nine in ten women who get checked will have something benign — atrophy of the vaginal and uterine lining (by far the most common cause), a polyp, an effect of hormone therapy. Both halves of that number matter. It is not a death sentence. It is also a one-in-eleven chance of a cancer that is highly curable if you go now and much less so if you wait a year. And the benign explanation is never assumed — it is confirmed, after assessment. Nothing about "it was only a tiny bit" or "it stopped on its own" lowers that number.
Two traps to know about:
- "My scan was fine." A transvaginal ultrasound showing a thin endometrium is reassuring, and a lining of 4 mm or less makes cancer very unlikely. But it does not close the file. If bleeding continues or comes back after a normal scan, guidelines are explicit that you need further assessment — usually an endometrial biopsy or a hysteroscopy, which looks directly inside the uterus. Persistent bleeding overrides a reassuring scan.
- "I'm on HRT, so bleeding is expected." Some bleeding patterns on hormone therapy genuinely are expected — sequential regimens are designed to produce a monthly bleed. But unscheduled bleeding on continuous combined therapy, bleeding that starts after six months of settled use, or bleeding on estrogen without adequate progesterone should be investigated, not assumed. Tell your prescriber; do not adjust anything yourself.
What are the symptoms of endometrial cancer?
| Symptom | What it looks like | How to read it |
|---|---|---|
| Postmenopausal bleeding | Any bleeding or spotting — pink, red or brown — 12+ months after your last period | The single most important sign. Present in the large majority of cases. Always needs assessment, however light, however brief |
| Heavy, prolonged or between-period bleeding (perimenopause) | Periods soaking through protection hourly, lasting more than 7 days, clots larger than a 10p coin, bleeding between periods, bleeding after sex | Cycles get erratic in perimenopause — but heavier, longer and inter-menstrual bleeding is not something to simply wait out. It deserves evaluation, especially over 45 |
| Watery or blood-tinged discharge | Thin, watery, pink or brownish discharge, sometimes with an odour; may occur without frank bleeding | A classic missed sign. After menopause, new watery or blood-stained discharge can be the only symptom of endometrial cancer and must be checked — do not treat it yourself and do not wait to see whether it settles |
| Pelvic pain or pressure | Persistent ache low in the pelvis, cramping, a feeling of fullness | Usually a later sign, and rarely the first one. Common benign causes exist — but new, persistent pelvic pain at midlife should be assessed |
| Unintended weight loss, fatigue, appetite loss | Losing weight without trying; feeling wiped out | Later, more advanced disease. Not something to wait for. If you are waiting for these before seeing someone, you have waited too long |
| Pain during sex, difficulty or pain passing urine | New, persistent | Non-specific and usually benign at midlife (genitourinary syndrome of menopause is far more common) — but worth mentioning alongside any bleeding |
A note about age: endometrial cancer is mostly a disease of the years after menopause — median age at diagnosis is in the early sixties — but a meaningful minority of cases occur before 55, and it is being diagnosed in younger women more often than it used to be. Being 46 is not a reason to be dismissed.
Why does a Pap smear not detect endometrial cancer?
This is the misconception that costs women the most time, and it is worth being blunt about. A Pap smear (cervical screening) samples cells from the cervix. It is designed to find cervical pre-cancer and HPV. It is not a test for the lining of the uterus.
Endometrial cancer cells sometimes shed downward and are picked up incidentally on a Pap — but this happens in a minority of cases and cannot be relied on. A normal cervical screening result, however recent, says nothing about your endometrium. Many women (and some clinicians) hear "your smear was clear" and mentally file the bleeding as handled. It is not handled.
The harder truth underneath: there is no population screening test for endometrial cancer. No blood test, no scan, no swab is recommended for symptom-free women at average risk. Nothing is going to catch this for you in the background. The symptom is the screening test — which is exactly why bleeding must be acted on rather than absorbed.
(Women with Lynch syndrome are the exception. They are usually offered specialist surveillance and a discussion about risk-reducing surgery, because their lifetime risk is in a different league.)
What raises the risk — and what lowers it?
Almost every risk factor on this list runs through the same mechanism: estrogen acting on the endometrium without enough progesterone to balance it. Estrogen tells the lining to grow; progesterone tells it to stop and shed. Take away the brake, and years of unopposed growth raise the chance that a cell goes wrong.
| Factor | Direction | Why, honestly |
|---|---|---|
| Obesity | Increases risk — the largest modifiable factor | Fat tissue converts other hormones into estrogen, so more body fat means more lifelong estrogen exposure — and after menopause it is the main source. Risk rises steeply with BMI; women with a BMI in the obese range have roughly two to three times the risk, and higher still at the top of the range. Obesity is thought to account for a large share of cases in high-income countries |
| Estrogen without progesterone | Increases risk substantially | Estrogen-only hormone therapy in a woman who still has her uterus is the textbook example. This is precisely why prescribers pair estrogen with a progestogen (or a progesterone-releasing IUD) when the uterus is intact. Never stop or change a hormone regimen on your own — talk to your prescriber |
| Tamoxifen | Increases risk (postmenopausal women) | Tamoxifen blocks estrogen in breast tissue but acts estrogen-like on the endometrium. Risk is roughly two to three times higher. For most women the breast-cancer benefit clearly outweighs it — the point is not to stop the drug, it is to report any bleeding immediately |
| PCOS | Increases risk | Infrequent ovulation means infrequent progesterone, so the lining is under-opposed for years. Often compounded by insulin resistance and higher body weight |
| Never having been pregnant; infertility | Increases risk | Pregnancy is a long progesterone-dominant break for the endometrium. Fewer or no pregnancies means fewer breaks |
| Early first period, late menopause | Increases risk | More menstrual cycles across a lifetime = more cumulative estrogen exposure. Menopause after ~55 raises risk |
| Type 2 diabetes | Increases risk | Associated with roughly double the risk. Partly tangled up with body weight, but insulin and IGF signalling appear to contribute independently |
| Lynch syndrome (and some family history) | Increases risk sharply | This inherited condition carries a lifetime endometrial cancer risk of roughly 40-60% — often the first cancer a woman with Lynch develops. If bowel, endometrial or ovarian cancers cluster in your family, especially under 50, ask about genetic assessment |
| Endometrial hyperplasia (especially with atypia) | Precursor condition | An over-thickened lining. Atypical hyperplasia carries a high risk of progressing to, or coexisting with, cancer — it is treated, not watched |
| Combined oral contraceptives | Protective | Well-established: the pill roughly halves risk with long use, and the protection persists for decades after stopping. One of the most durable non-contraceptive benefits in medicine |
| Progesterone-releasing IUD (LNG-IUS) | Protective | Delivers progestogen straight to the endometrium, thinning it. Used both to lower risk and to treat hyperplasia. Also why it is a common uterine-protection option alongside estrogen therapy |
| Physical activity and lower body weight | Protective | Regular activity is associated with lower risk, partly but not only through weight. Substantial, sustained weight loss is associated with meaningfully lower risk in observational data |
What is not on this list matters too. Endometrial cancer is not caused by HPV, it is not caused by tampons or menstrual cups, and — despite persistent internet claims — there is no good evidence that soy or phytoestrogen foods raise your risk.
Is it cancer, or is it just perimenopause?
Most abnormal bleeding at midlife is not cancer. Fibroids, polyps, adenomyosis, thyroid disease, a coagulation issue, and the plain hormonal turbulence of perimenopause all cause heavy or erratic bleeding, and they are all far more common. Cycles that shorten, then lengthen, then skip are the normal shape of the transition — see irregular periods in perimenopause. But "most" is not "yours" until someone has looked.
The distinction is context, not vibes:
- Postmenopausal (12+ months since your last period): any bleeding or new watery/bloody discharge → get seen. No exceptions, no waiting to see if it recurs.
- Perimenopausal: variable timing is expected. Bleeding that is heavier, longer, between periods, or after sex is not "just perimenopause" — it warrants evaluation, particularly if you are over 45 or carry risk factors above. See heavy periods and spotting between periods.
- Discharge without bleeding: before menopause, most white, clear, pink or brown discharge is normal or infection-related. After menopause, new persistent watery or blood-tinged discharge is a symptom to report — not something to self-treat with an over-the-counter product.
What happens when you get checked?
Knowing the pathway removes some of the dread. Typically:
- History and pelvic exam. Bring dates: when the bleeding happened, how much, whether it recurred, what medications and hormones you take.
- Transvaginal ultrasound. Measures endometrial thickness. In postmenopausal women, a thin lining (≤4 mm) makes cancer unlikely — but it does not settle the question if bleeding carries on or comes back. Persistent or recurrent bleeding takes you to step 3 regardless of the scan.
- Endometrial biopsy. A thin tube samples the lining, usually in clinic, usually in minutes. It can be crampy — ask what pain relief is offered before the day, and ask again if you find it intolerable.
- Hysteroscopy (± D&C) if the biopsy is inconclusive, if bleeding persists, or if a polyp is suspected. A camera looks directly inside the uterus.
Diagnosis at an early stage is common precisely because bleeding drives women to the door: most endometrial cancers are found while still confined to the uterus, where treatment (usually hysterectomy) is curative for the large majority.
If you are being brushed off
It happens, and it should be named. Women report being told bleeding is "just the change", being handed tranexamic acid without investigation, or being reassured on the strength of a normal smear. Guidelines in both the US and UK are clear that postmenopausal bleeding requires investigation, and that persistent bleeding requires investigation even after a reassuring scan. You are entitled to ask, in these words: "I understand it's probably benign — I'd like an endometrial assessment documented, or a note in my record explaining why it isn't indicated." That single sentence changes conversations. Writing your symptoms down in advance helps too — our doctor-visit report tool can structure it for you.
When to see a doctor
Book an urgent appointment (days, not months) if you are postmenopausal and have:
- Any vaginal bleeding or spotting at all — even once, even a trace, even if it stopped
- New watery, pink, brown or blood-tinged discharge
- Unscheduled or unexpected bleeding while on hormone therapy
- Any bleeding while taking tamoxifen
- Bleeding that returns after a normal ultrasound — a thin lining does not rule this out if the bleeding keeps happening
Make an appointment soon if you are perimenopausal or still cycling and have:
- Periods that have become much heavier or longer than your normal (soaking through protection hourly, flooding, large clots)
- Bleeding between periods, or bleeding after sex
- Persistent pelvic pain or pressure that is new for you
- Any of the above plus risk factors: obesity, PCOS, diabetes, estrogen therapy without progesterone, a family history of bowel/uterine/ovarian cancer
Seek same-day care for very heavy bleeding with dizziness, breathlessness or fainting — that is a bleeding emergency regardless of the cause, and heavy loss over time also drives iron-deficiency anaemia.
None of this is a diagnosis, and this article cannot examine you. But endometrial cancer is one of the few cancers that reliably tells you it is there. The only way that early warning gets wasted is if the message is ignored — so please don't ignore it. More on symptoms across the pelvis in our gynecologic health guide.
]]>
